These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 26597840

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO, den Boon S, Meya D, Cattamanchi A, Worodria W, Davis JL, Walter ND, Yoo SD, Kalema N, Haller B, Huang L, International HIV-Associated Opportunistic Pneumonias (IHOP) Study.
    J Acquir Immune Defic Syndr; 2013 Jun 01; 63(2):189-94. PubMed ID: 23542636
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
    Smitson CC, Tenna A, Tsegaye M, Alemu AS, Fekade D, Aseffa A, Blumberg HM, Kempker RR.
    PLoS One; 2014 Jun 01; 9(1):e85698. PubMed ID: 24465651
    [Abstract] [Full Text] [Related]

  • 27. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker® lateral flow assay.
    Karaman E, Ilkit M, Kuşçu F.
    Mycoses; 2019 Oct 01; 62(10):961-968. PubMed ID: 31344286
    [Abstract] [Full Text] [Related]

  • 28. Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.
    Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR.
    J Acquir Immune Defic Syndr; 2019 Feb 01; 80(2):182-189. PubMed ID: 30399034
    [Abstract] [Full Text] [Related]

  • 29. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
    Alemu AS, Kempker RR, Tenna A, Smitson C, Berhe N, Fekade D, Blumberg HM, Aseffa A.
    PLoS One; 2013 Feb 01; 8(3):e58377. PubMed ID: 23469276
    [Abstract] [Full Text] [Related]

  • 30. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Ford N, Shubber Z, Jarvis JN, Chiller T, Greene G, Migone C, Vitoria M, Doherty M, Meintjes G.
    Clin Infect Dis; 2018 Mar 04; 66(suppl_2):S152-S159. PubMed ID: 29514236
    [Abstract] [Full Text] [Related]

  • 31. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
    Zuma P, Ramsamy Y, Mlisana K, Archary M.
    Pediatr Infect Dis J; 2020 Mar 04; 39(3):217-220. PubMed ID: 31725553
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and Sequelae of Cryptococcal Antigenemia in Antiretroviral Therapy-Experienced Populations: An Evaluation of Reflex Cryptococcal Antigen Screening in Botswana.
    Hurt WJ, Tenforde MW, Molefi M, Mitchell HK, Milton T, Azama MS, Goercke I, Mulenga F, Tlhako N, Tsholo K, Srivastava T, Leeme TB, Simoonga G, Muthoga C, Lechiile K, Mine M, Jarvis JN.
    Clin Infect Dis; 2021 May 18; 72(10):1745-1754. PubMed ID: 32236414
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP, Roy M, Mendes JF, Zulu TG, Chiller TM, Karstaedt AS.
    HIV Med; 2015 Sep 18; 16(8):468-76. PubMed ID: 25689352
    [Abstract] [Full Text] [Related]

  • 36. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
    Drain PK, Galagan SR, Govere S, Krows M, Thulare H, Wallis CL, Gosnell BI, Moosa MY, Celum C, Bassett IV.
    J Acquir Immune Defic Syndr; 2021 Aug 15; 87(5):1205-1213. PubMed ID: 33990495
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM, Cassim N, Sriruttan C, Mhlanga M, Govender NP, Glencross DK.
    PLoS One; 2018 Aug 15; 13(6):e0198993. PubMed ID: 29894509
    [Abstract] [Full Text] [Related]

  • 39. Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.
    Osazuwa F, Dirisu JO, Okuonghae PE, Ugbebor O.
    Oman Med J; 2012 May 15; 27(3):228-31. PubMed ID: 22811773
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.